References
- Friedman S A, Taylor R N, Roberts J M. Pathophysiology of pre‐eclampsia. Clin Perinatol 1991; 4: 661–682
- Weiner C, Knowles R, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994; 171: 838–843, [PUBMED], [INFOTRIEVE], [CSA]
- Miller V. Vascular control during pregnancy. Extending experimental findings to humans. Circ Res 2000; 87: 344–345, [PUBMED], [INFOTRIEVE]
- Sladek S M, Magness R R, Conrad K P. Nitric oxide and pregnancy. Am J Physiol 1997; 272: R441–R463, [PUBMED], [INFOTRIEVE]
- Davidge S T, Stranko C P, Roberts J M. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996; 174: 1008–1013, [PUBMED], [INFOTRIEVE], [CSA]
- Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi K I, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 1996; 41: 189–193, [PUBMED], [INFOTRIEVE], [CSA]
- Moncada S, Higgs E A. The L‐arginine: nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hobbs A J, Ignarro L J. Nitric oxide‐cyclic GMP signal transduction system. Methods Enzymol 1996; 269: 134–148, [PUBMED], [INFOTRIEVE]
- Hobbs A J. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 1997; 18: 484–491, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hobbs A J. Soluble guanylate cyclase: an old therapeutic target re‐visited. Br J Pharmacol 2002; 136: 637–640, [PUBMED], [INFOTRIEVE], [CSA]
- Yallampalli C, Garfield R. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169: 1316–1320, [PUBMED], [INFOTRIEVE], [CSA]
- Conrad K P, Joffe G M, Kruszyna R, Rochelle L G, Smith R P, Chavez J E, Mosher M D. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 556–571
- Conrad K, Kerchner L, Mosher M. Plasma and 24‐h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet. Am J Physiol 1999; 277: F48–F57, [PUBMED], [INFOTRIEVE]
- Seligman S P, Buyon J P, Clancy R M, Young B K, Abramson S B. The role of NO in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171: 944–948, [PUBMED], [INFOTRIEVE], [CSA]
- Silver R K, Kupferminc M J, Russell T L, Adler L, Mullen T A, Caplan M S. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 1996; 175: 1013–1017, [PUBMED], [INFOTRIEVE], [CSA]
- Konijnenberg A, van der Post J, Mol B, Schaap M C, Lazarov R, Bleker O P, Boer K, Sturk A. Can flow cytometric detection of platelet activation early predict the occurrence of pre‐eclampsia?. Am J Obstet Gynecol 1997; 177: 434–442, [PUBMED], [INFOTRIEVE], [CSA]
- Hutt R, Ogunniyi S, Sullivan M, Elder M G. Increased platelet volume and aggregation precede the onset of pre‐eclampsia. Obstet Gynecol 1994; 83: 146–149, [PUBMED], [INFOTRIEVE], [CSA]
- Yusuf A, van Iddeking B, Paul C, Sullivan H F, Elder M G. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre‐eclampsia. Br J Obstet Gynaecol 1993; 100: 216–220
- Teran E, Escudero C, Vivero S. Physiological changes in platelet aggregation and nitric oxide levels during menstrual cycle in healthy women. Nitric Oxide 2002; 7: 217–220, In press[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lopez‐Jaramillo P, Narvaez M, Weigel R M, Yepez R. Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. Br J Obstet Gynaecol 1989; 96: 648–655, [CSA]
- Norris L, Sheppard B, Burke G, et al. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1994; 101: 209–214, [PUBMED], [INFOTRIEVE], [CSA]
- Boehlen F, Hohlfeld P, Extermann P, Perneger T, De Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 2000; 95: 29–33, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Missfelder‐Lobos H, Teran E, Lees C, Albaiges G, Nicolaides K H. Platelet changes and subsequent development of pre‐eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet Gynecol 2002; 19: 443–448, [CROSSREF], [CSA]
- Hardy E, Rubin P C, Horn E H. Effects of nitric oxide donors in vitro on the arachidonic acid‐induced platelet release reaction and platelet cyclic GMP concentration in pre‐eclampsia. Clin Sci (Lond) 1994; 86: 195–202, [CSA]
- Neri I, Piccinini F, Marietta M, Facchinetti F, Volpe A. Platelet responsiveness to L‐arginine in hypertensive disorders of pregnancy. Hypertens Pregnancy 2000; 19: 323–330, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lopez‐Jaramillo P, Narvaez A, Calle J, Rivera J, Jácome P, Ruano C, Nava E. Cyclic guanosine‐3′,5′‐monophosphate concentrations in preeclampsia: effects of hydralazine. Br J Obstet Gynaecol 1996; 103: 33–38, [CSA]